Medtronic (MDT) Turnaround Accelerates: UBS Upgrade Signals Sustainable Growth After Decade-High Revenue Surge
Medtronic plc (NYSE: MDT) is capturing Wall Street’s attention after UBS upgraded the medical device giant to a Buy rating from Neutral, citing a credible turnaround underway. The upgrade arrives on the heels of the company’s strongest annual revenue growth in a decade, prompting investors to reassess whether the Dublin-headquartered conglomerate has finally broken out … Read more








